Trade Show Hosted Event

Meet Datwyler at
COPHEX

Engaging Korea's Pharmaceutical Community on Home-Based Drug Delivery, Elastomer Innovation, and PFAS Regulatory Clarity

Datwyler exhibited at COPHEX 2026 at KINTEX in Seoul, showcasing the NeoFlex™ plunger platform and biologics packaging solutions at Booth #5B511, and hosting an exclusive seminar on home-based drug delivery and PFAS regulatory guidance.

Date March 31, 2026 – April 3, 2026

Location KINTEX 1 | South Korea

Details Booth #5B511

Event Recap View Event Details

Event Overview

Where Home-Based Drug Delivery Meets Korea's Pharmaceutical Innovation Community

Datwyler exhibited at COPHEX 2026 at KINTEX in Seoul, connecting with pharmaceutical manufacturers, packaging professionals, and healthcare industry leaders at Korea's leading pharmaceutical and cosmetics exhibition. At Booth #5B511, our team showcased the NeoFlex™ plunger platform, high-performance biologics components, and drug delivery solutions for home-based and patient-centric care. Datwyler also hosted an exclusive seminar — "Enabling the Future of Home-Based Drug Delivery: Elastomer Solutions, System Compatibility, and Navigating PFAS Regulations" — featuring two sessions: Yitian Xiao, Global Biologics Product Expert, on practical system enablement for home-based drug delivery and the role of NeoFlex™ across prefilled syringe and cartridge platforms; and Simon Kervyn, Manager Surface Development, providing clarity on the evolving PFAS regulatory landscape and how to confidently evaluate coating options for long-term compliance and sustainability.

Featured Presentations

Presentation Details

Enabling the Future of Home-Based Drug Delivery: Elastomer Solutions, System Compatibility, and Navigating PFAS Regulations

Date & Time April 1, 2026 • 2:00 PM

Location KINTEX 1, Meeting Room 209, Goyang-si, Gyeonggi-do

As home-based drug delivery continues to expand, elastomer components play a critical role in ensuring safe, reliable, and user-friendly drug delivery systems. Pharmaceutical manufacturers are therefore increasingly focused on component compatibility, process efficiency, and regulatory confidence. This seminar highlights how advanced elastomer solutions support these evolving needs across drug delivery applications.

Session 1: Home-Based Drug Delivery – Practical System Enablement

Speaker: Yitian Xiao, Global Biologics Product Expert

This session focuses on home-based drug delivery systems and the role of NeoFlex™ plungers in ensuring reliable performance across the main prefilled syringe and cartridge platforms. Key topics include:

Latest drug delivery trends in the EU and US (such as large-volume subcutaneous injection used in biopharmaceuticals targeting oncological, autoimmune, neurological, and cardiovascular diseases)
Compatibility with complex formulations and sensitive biologics, ensuring low extractables and leachables
Reliable container closure integrity (CCI) and smooth, consistent functionality across delivery devices
The critical role of elastomer components in enabling seamless implementation and customer transition from development to commercial production
Practical insights into equipment selection and line-setting processes, supporting efficient and stable operations
High level US regulatory updates for elastomer components (such as USP 382)

Session 2: PFAS Regulations & Coating Solutions – Clarity for Informed Decisions

Speaker: Simon Kervyn, Manager Surface Development

This session provides clear guidance on the PFAS regulatory landscape and its impact on coated rubber components. Key topics include:

Overview of current and emerging PFAS regulations relevant to pharmaceutical packaging
Customer questions around specific polymer types—such as OmniFlex® and NeoFlex™ , ETFE—and how these relate to regulatory expectations
Datwyler’s material strategy and the performance advantages, safety, and regulatory records of our coating solutions
How to confidently evaluate coating options while balancing functionality, compliance, and long-term sustainability

Simultaneous interpretation between English and Korean will be arranged.

View Yitian Xiao View Simon Kervyn

Speaker Spotlight

Meet the Speakers

Yitian Xiao

Global Biologics Product Expert | Datwyler

Yitian Xiao is currently a Global Biologics Product Expert at Datwyler and brings a breadth of experience leading thought leadership initiatives supporting the evolving needs of the biologics industry. He previously worked in a commercial development role at Becton Dickinson (BD) providing pharmaceutical customers with consultation on BD products, services, and solutions to meet their development timelines. Prior to BD, he was a combination product R&D engineer at AstraZeneca responsible for managing technical aspects of device development, such as user needs, test method development, design verification, and design validation.

Yitian holds a M.Eng in Biomedical Engineering from Cornell University and a B.S. in Biomedical Engineering from Georgia Tech.

View LinkedIn

Simon Kervyn

Manager, Surface Development | Datwyler

Simon Kervyn graduated as a PhD in organic chemistry and materials from the University of Namur, Belgium in 2012. After research stays at National Institute of Materials Sciences in Tokyo and at UCLA, Los Angeles, he worked at the Coatings Research Institute in Belgium.

In 2017, he joined Datwyler R&D and now works as manager surface development. In this position he performs customer’s dedicated research to optimize the selection of rubber components to their applications. He also works on the development of coated products for the Datwyler portfolio. Furthermore, he supports analytical investigations of extractables including PFAS.

View LinkedIn

Solutions Spotlight

What We're Showcasing at COPHEX

Explore the solutions and technologies most relevant to this event.

Featured Solution

Exclusive Seminar: Enabling the Future of Home-Based Drug Delivery

Datwyler hosted an exclusive seminar at COPHEX 2026 featuring two sessions: Yitian Xiao, Global Biologics Product Expert, on practical system enablement for home-based drug delivery and the role of NeoFlex™ across prefilled syringe and cartridge platforms; and Simon Kervyn, Manager Surface Development, providing clarity on the evolving PFAS regulatory landscape and how to evaluate coating options for long-term compliance and sustainability.

Featured Solution

The NeoFlex™ Plunger Platform for Large-Volume Injectables

Datwyler's NeoFlex™ plunger — the first-to-market 20ml universal plunger — was engineered to support the growing demand for large-volume injectable therapies, offering compatibility across multiple prefilled syringe and cartridge platforms, simplified development, and reduced qualification complexity for biologic and high-dose therapies.

Featured Solution

Navigating PFAS Regulations with Confidence

Datwyler provided clarity on the evolving PFAS regulatory landscape and its impact on coated rubber components, offering pharmaceutical manufacturers practical guidance on evaluating coating options — including OmniFlex® and NeoFlex™ monomeric PFAS-free solutions — while balancing functionality, compliance, and long-term sustainability.

Additional Information